Ackman is 'profoundly' sorry for US$4b Valeant 'mistake'
Add BT as a preferred source
New York
BILL Ackman "deeply and profoundly" apologised for his investment in Valeant Pharmaceuticals International Inc, a "huge mistake" that cost his firm US$4 billion.
In his annual letter to investors in his publicly traded fund Pershing Square Holdings Ltd, Mr Ackman in part blamed Valeant's overpaying for Salix Pharmaceuticals in 2015 for the drugmaker's downfall. But he also took blame for misjudging the company's management and its aggressive strategy.
TRENDING NOW
Soon Su Lin to step down as Frasers Property CEO; Tan Wee Hsien named successor
Interest in SGX-listed small and mid-cap stocks returning, but analysts flag overvalued tech stocks
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
Taiwan’s wealthy seeks diversification to Singapore, sparking private banking race: Bloomberg
